Emergent BioSolutions Inc. — Director's Dealing 2017

Nov 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-11-07

Reporting Person: JOULWAN GEORGE A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-07	Common Stock	M	3946	$15.97	Acquired	34323	Direct
2017-11-07	Common Stock	S	3946	$41.24	Disposed	30377	Direct
2017-11-07	Common Stock	M	10305	$18.64	Acquired	40682	Direct
2017-11-07	Common Stock	S	10305	$41.24	Disposed	30377	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-07	Employee Stock Option (Right to buy)	$15.97	M	3946	Disposed	2020-07-17	Common Stock (3946)	Direct
2017-11-07	Employee Stock Option (Right to buy)	$18.64	M	10305	Disposed	2021-05-22	Common Stock (10305)	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.45, inclusive.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.